David R Epstein's Net Worth

$7.48 Million

Estimate Recalculated Nov 7, 2024 04:53PM EST

Who is David R Epstein

David R Epstein has an estimated net worth of $7.48 Million. This is based on reported shares across multiple companies, which include INTERNATIONAL FLAVORS & FRAGRANCES INC, Rubius Therapeutics, Inc., Molecular Insight Pharmaceuticals, Inc., Senti Biosciences, Inc., Opy Acquisition Corp. I, Axcella Health Inc., Evelo Biosciences, Inc., Seagen Inc., and Tempus AI, Inc..

SEC CIK

David R Epstein's CIK is 0001445826

Past Insider Trading and Trends

2020 was David R Epstein's most active year for acquiring shares with 29 total transactions. David R Epstein's most active month to acquire stocks was the month of April. 2021 was David R Epstein's most active year for disposing of shares, totalling 23 transactions. David R Epstein's most active month to dispose stocks was the month of November. 2020 saw David R Epstein paying a total of $557,942.11 for 427,329.533 shares, this is the most they've acquired in one year. In 2023 David R Epstein cashed out on 654,215 shares for a total of $6,019,369.20, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INTERNATIONAL FLAVORS & FRAGRANCES INC

Investor
Updated Nov 04, 2020
Form 4
20.10%
1.07K
$105.07
$112.50K
Nov 04, 2020
7.44K
Grant
Nov 02
Form 4
19.94%
1.05K
$131.31
$107.41
May 08, 2020
6.30K
Grant
May 06
Form 4
May 05, 2020
5.25K
Acq/Dis
May 01
Form 4
12.35%
462.05
$121.74
$56.25K
Nov 05, 2019
5.20K
Grant
Nov 01
Form 4
26.95%
997.00
May 03, 2019
4.70K
Acquisition
May 01 - May 02
Form 4
May 03, 2018
2.75K
Acq/Dis
May 03
Form 4
874.00
May 03, 2018
874.00
Grant
May 02
Form 4
882.00
May 05, 2017
882.00
Grant
May 03
Form 4
May 03, 2017
1.84K
Acq/Dis
May 02
Form 4
Feb 03, 2017
899.00
Acq/Dis
Feb 01
Form 4
160.00
$118.46
$18.95K
Dec 06, 2016
160.00
Grant
Feb 01
Form 4
420.00
$133.84
$56.21K
Nov 03, 2016
420.00
Grant
Nov 01
Form 4
938.00
May 03, 2016
938.00
Grant
May 02
Form 4
319.00
Feb 02, 2016
319.00
Grant
Feb 01
Form 3
Jan 11, 2016
Showing 15 results

Rubius Therapeutics, Inc.

Investor
Updated May 13, 2022
Form 4
499.76K
May 13, 2022
499.76K
Grant
May 12
Form 4
0.64%
30.00K
$1.44
$43.33K
Apr 22, 2022
4.72M
Purchase
Apr 21
Form 4
27.92K
May 13, 2021
27.92K
Grant
May 12
Form 4
-0.57%
-26.70K
$14.93
-$398.56K
Feb 16, 2021
4.69M
Sale
Scheduled
Feb 11
Form 4
-2.05%
-98.74K
$14.88
-$1.47M
Feb 10, 2021
4.72M
Sale
Scheduled
Feb 08 - Feb 10
Form 4
115.77K
May 26, 2020
115.77K
Grant
May 21
Form 4
0.10%
5.00K
$3.76
$18.80K
Mar 19, 2020
4.82M
Purchase
Mar 17
Form 4
0.21%
10.00K
$3.91
$39.10K
Mar 17, 2020
4.81M
Purchase
Mar 13
Form 4
39.09K
May 28, 2019
39.09K
Grant
May 23
Form 4
1.90M
Jul 18, 2018
1.90M
Grant
Jul 17
Form 3
Jul 17, 2018
4.98M
Showing 11 results

Molecular Insight Pharmaceuticals, Inc.

Investor
Updated Sep 24, 2008
Form 4
25.00K
Sep 24, 2008
25.00K
Grant
Sep 22
Form 3
Sep 24, 2008
Showing 2 results

Senti Biosciences, Inc.

Investor
Updated Jul 15, 2022
Form 4
125.00K
Jul 15, 2022
125.00K
Grant
Jul 13
Form 4
Jun 10, 2022
123.25K
Options
Jun 08
Form 3
May 25, 2021
10.73K
Showing 3 results

Opy Acquisition Corp. I

Investor
Updated Oct 26, 2021
Form 3
Oct 26, 2021
Showing 1 results

Axcella Health Inc.

Investor
Updated Jun 03, 2022
Form 4
28.92%
47.06K
Jun 03, 2022
209.76K
Grant
May 19
Form 4
30.73%
50.00K
Mar 21, 2022
212.70K
Options
Mar 17 - Mar 18
Form 4
19.39%
26.18K
$1.91
$50.00K
Mar 18, 2022
161.16K
Purchase
Mar 16
Form 4
Feb 23, 2022
136.52K
Options
Feb 18
Form 4
Jan 20, 2022
136.52K
Options
Jan 18
Form 4
Dec 20, 2021
136.52K
Options
Dec 17
Form 4
Nov 22, 2021
136.52K
Options
Nov 18
Form 4
Oct 19, 2021
136.52K
Options
Oct 18
Form 4
Sep 20, 2021
136.52K
Options
Sep 17
Form 4
Aug 19, 2021
136.52K
Options
Aug 18
Form 4
Jul 20, 2021
136.52K
Options
Jul 16
Form 4
Jun 21, 2021
136.52K
Options
Jun 18
Form 4
May 20, 2021
136.52K
Options
May 18
Form 4
Apr 20, 2021
136.52K
Options
Apr 18
Form 4
138.42K
Mar 22, 2021
138.42K
Grant
Mar 18
Form 4
6.80K
Jun 08, 2020
6.80K
Grant
Jun 05
Form 4
100.00K
May 22, 2020
100.00K
Grant
May 20
Form 4
73.42%
50.00K
$4.75
$237.50K
May 20, 2020
118.10K
Purchase
May 18
Form 4
27.78%
14.80K
$3.66
$54.24K
Mar 02, 2020
68.10K
Purchase
Feb 27 - Feb 28
Form 4
39.18%
15.01K
$3.57
$53.63K
Dec 03, 2019
53.30K
Purchase
Nov 26 - Nov 27
Form 4
39.18%
15.01K
$3.57
$53.63K
Dec 02, 2019
53.30K
Purchase
Nov 26 - Nov 27
Form 4
100.00K
Aug 23, 2019
100.00K
Grant
Aug 21
Form 4
22.14%
6.94K
$7.00
$48.62K
Aug 05, 2019
38.29K
Purchase
Aug 01 - Aug 02
Form 4
3.29%
1.00K
$7.55
$7.55K
Jul 18, 2019
31.35K
Purchase
Jul 17
Form 4
23.60%
5.80K
$8.24
$47.74K
Jul 10, 2019
30.35K
Purchase
Jul 08 - Jul 10
Form 4
31.42%
4.56K
$8.76
$39.92K
Jul 03, 2019
19.06K
Purchase
Jul 01 - Jul 03
Form 4
37.93%
5.50K
$10.02
$55.13K
Jul 01, 2019
20.00K
Purchase
Jun 27 - Jun 28
Form 4
14.50K
$9.57
$138.77K
Jun 27, 2019
14.50K
Purchase
Jun 26
Form 4
11.00K
May 24, 2019
11.00K
Grant
May 22
Form 3
May 08, 2019
Showing 30 results

Evelo Biosciences, Inc.

Investor
Updated Jun 30, 2022
Form 4
Jun 30, 2022
93.93K
Options
Jun 30
Form 4
20.00K
Jun 13, 2022
20.00K
Grant
Jun 10
Form 4
Jun 01, 2022
93.93K
Options
May 31
Form 4
25.57%
17.12K
$1.46
$25.00K
May 31, 2022
84.08K
Purchase
May 27
Form 4
May 02, 2022
76.81K
Options
May 02
Form 4
Apr 01, 2022
76.81K
Options
Mar 31
Form 4
Mar 01, 2022
76.81K
Options
Feb 28
Form 4
Jan 31, 2022
76.81K
Options
Jan 31
Form 4
Jan 03, 2022
76.81K
Options
Dec 31
Form 4
Dec 01, 2021
76.81K
Options
Nov 30
Form 4
Nov 01, 2021
76.81K
Options
Nov 01
Form 4
Oct 01, 2021
76.81K
Options
Oct 01
Form 4
Sep 03, 2021
76.81K
Options
Sep 03
Form 4
59.11K
Jul 02, 2021
59.11K
Grant
Jun 30
Form 4
77.00%
7.70K
$6.66
$51.26K
Dec 14, 2020
17.70K
Purchase
Dec 11
Form 4
104.14K
Oct 14, 2020
104.14K
Grant
Oct 11
Form 4
10.00K
$4.44
$44.44K
Sep 01, 2020
10.00K
Purchase
Aug 28 - Aug 31
Form 4
150.00K
Sep 17, 2019
150.00K
Grant
Sep 14
Form 4
15.69K
Jun 13, 2019
15.69K
Grant
Jun 12
Form 3
May 08, 2018
Showing 20 results

Seagen Inc.

CEO
Updated Dec 15, 2023
Form 4
-100.00%
-643.60K
$229.00
-$3.76M
Dec 15, 2023
Disposition
Dec 14
Form 4
-7.21%
-10.62K
$213.01
-$2.26M
Nov 13, 2023
136.60K
Sale
Nov 10
Form 4
36.86%
39.65K
Aug 17, 2023
147.22K
Grant
Aug 15
Form 4
750.74K
Nov 14, 2022
750.74K
Grant
Nov 09
Form 3
Nov 10, 2022
Showing 5 results

Tempus AI, Inc.

Investor
Updated Jun 17, 2024
Form 4
28.51K
Jun 17, 2024
28.51K
Grant
Jun 13
Form 3
Jun 13, 2024
Showing 2 results